Pharmaceutical Executive-12-01-2014

How pharma companies can catch up to the requirements of the modern marketing model.

New ways for pharma to make sure its sales reps stay sharp amid a flood of new information and a more complex selling climate.

THE CALENDAR SAYS IT'S WRAP UP TIME, not just for gifts, but for some of the trends that shaped big Pharma-for good or bad-during the past year. A simple way to close the book on 2014 is to draw some insights from our three feature stories this month.

Foreign governments are enacting anti-fraud legislation as part of broader efforts to crack down on corrupt practices involving pharmaceutical companies and healthcare professionals.

Two words define the future of commercialization project management: Faster and Better

Building an effective drug forecasting model today requires a revamped approach.

partnerships, big pharma, data exchange, Business Development, M&A, Business Strategy, information exchange, dealmaking, Rebecca Ashkenazy, Alex Chang, Cyndi Green, Ted Miller, Christine de los Reyes, targeted medicine, R&D productivity

Cleveland Clinic's Pick of Top 10 Advances for 2015.

Once considered a healthcare backwater, Algeria's expanding pharmaceuticals market is taking the African continent by storm.